LI
PAHC icon

Leap Investments’s Phibro Animal Health PAHC Stock Holding History

Leap Investments’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,800
Closed -$380K – 538
2019
Q3 		$380K Buy
+17,800
New +$488K 0.19% 197

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Leap Investments's PAHC Position: Q4 2019 in Review

Leap Investments sold out of Phibro Animal Health (PAHC) in Q4 2019, closing a stake of 17,800 shares — an estimated $380K sold.

Leap Investments first reported a position in PAHC in Q3 2019 and held it in 1 quarter. The position peaked at $380K in Q3 2019. 155 funds tracked by Wall St. Rank hold PAHC as of Q4 2019.

  • Leap Investments reported no remaining Phibro Animal Health position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 17,800 Phibro Animal Health shares in Q4 2019, an estimated $380K.
  • Leap Investments first reported a position in Phibro Animal Health in Q3 2019 and held it in 1 quarter.
  • Leap Investments's Phibro Animal Health position peaked at $380K in Q3 2019.
  • 155 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.